A month ago the Lancet and the New England Journal of Medicine each retracted a major study on Covid-19 drug therapies. One article had been up for more than a month, the other for less than two weeks. Both were based on faked data. That the rush to publish on Covid-19 led established researchers, reviewers and journals to skip elementary checks is deplorable, if not entirely surprising.